TRV GP III, LLC
- SEC CIK
- 0001637299
- Latest filing
- Feb 14, 2024
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 7
- 0 vs. Q3 2021
- Portfolio value
- $399.6M
- −$127.2M (−24.1%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 5,524,031 | $139.0M | 34.8% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 5,839,160 | $78.8M | 19.7% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 2,422,549 | $70.1M | 17.6% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 3,962,202 | $70.1M | 17.5% | −1,000,000−20.2% | Reduced | History |
| VYGRVoyager Therapeutics, Inc. | COM | 6,391,176 | $17.3M | 4.3% | 00.0% | Unchanged | History |
| DBTXDecibel Therapeutics, Inc. | COM | 3,139,685 | $14.6M | 3.7% | 00.0% | Unchanged | History |
| JNCEJounce Therapeutics, Inc. | COM | 1,148,780 | $9.59M | 2.4% | −1,900,000−62.3% | Reduced | History |